DNA Electronics has raised the funding required to develop a line of semiconductor-based diagnostic testing products, with main shareholder Genting Berhad providing most of the cash.
UK-based semiconductor product maker DNA Electronics has raised the funding it needs to develop its Genalysis range of point-of-care genomic diagnostic products, with the majority of the capital being provided by its main shareholder, Edith Grove, a subsidiary of Malaysia-based conglomerate Genting Berhad.
Originally spun-out of Imperial College London, DNAe develops molecular interfaces and assays on a semiconductor platform.
Genalysis works as a sample-to-answer platform for nucleic acid detection, taking a swab or saliva sample and converting the DNA in…
